Since iPS cells show significant reprogramming variability, we also excluded the hotspots of aberrant reprogramming regions reported by Lister et al. [19] and still found FXS-associated DNA methylation changes only at the FMR1 locus (data not shown). The gene discussed is FMR1; the disease is fragile X syndrome.